Literature DB >> 31858092

The anti-inflammatory effects of low- and high-molecular-weight beta-glucans from Agrobacterium sp. ZX09 in LPS-induced weaned piglets.

Junqiu Luo1, Long Cheng, Yanjun Du, Xiangbing Mao, Jun He, Bing Yu, Daiwen Chen.   

Abstract

The physicochemical characteristics of beta-glucans determine the immune responses of the intestines and whole body. It is hypothesized that glucans with different molecular weights have diverse modes of action on LPS-mediated immune activity. This study aimed to verify the immune-modulatory effects of two types of beta-glucans in LPS-induced weaned piglets. The results indicated that dietary beta-glucan supplementation could prevent losses in body weight gain caused by LPS challenge. Supplementation with different molecular weights of beta-glucans decreased the production of IL-1β and TNF-α and increased IL-10 production, which is likely associated with key factors such as TLR4 and NF-κB. High-molecular-weight beta-glucans seemed to have a strong functional capacity to modulate the innate immune response through the Dectin-1 receptor. Therefore, the results indicate that supplementing piglets with Agrobacterium sp. ZX09 beta-glucans inhibits LPS-mediated depression in the growth performance and plays a protective role during LPS challenge possibly via the Dectin-1 receptor and the TLR4/NF-κB pathway. The results reveal the potential therapeutic activity of purified Agrobacterium sp. ZX09 beta-glucan following experimental LPS infusion.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31858092     DOI: 10.1039/c9fo00627c

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  1 in total

1.  Anti-Inflammatory Activity of Oat Beta-Glucans in a Crohn's Disease Model: Time- and Molar Mass-Dependent Effects.

Authors:  Ewa Żyła; Katarzyna Dziendzikowska; Dariusz Kamola; Jacek Wilczak; Rafał Sapierzyński; Joanna Harasym; Joanna Gromadzka-Ostrowska
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.